Results 321 to 328 of about 143,629 (328)

Human medicines European public assessment report (EPAR): Buvidal, buprenorphine, Opioid-Related Disorders, Date of authorisation: 20/11/2018, Status: Authorised

Case Medical Research, 2018
openaire   +1 more source

Human medicines European public assessment report (EPAR): Sixmo, buprenorphine, Opioid-Related Disorders, Date of authorisation: 20/06/2019, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine / naloxone, Opioid-Related Disorders, Date of authorisation: 10/11/2017, Revision: 2, Status: Authorised

Case Medical Research, 2019
openaire   +2 more sources

Human medicines European public assessment report (EPAR): Buvidal, buprenorphine, Opioid-Related Disorders, Date of authorisation: 20/11/2018, Revision: 1, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Suboxone, buprenorphine / naloxone, Opioid-Related Disorders, Date of authorisation: 26/09/2006, Revision: 15, Status: Authorised

Case Medical Research, 2019
openaire   +2 more sources

Human medicines European public assessment report (EPAR): Moventig, naloxegol, Constipation,Opioid-Related Disorders, Date of authorisation: 07/12/2014, Revision: 8, Status: Authorised

Case Medical Research, 2018
openaire   +1 more source

Human medicines European public assessment report (EPAR): Moventig, naloxegol, Constipation,Opioid-Related Disorders, Date of authorisation: 07/12/2014, Revision: 10, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Relistor, methylnaltrexone bromide, Opioid-Related Disorders,Constipation, Date of authorisation: 01/07/2008, Revision: 15, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source